After activated by IL-6 derived from metastasizing breast cancer cells, MDSCs can express both IL-6 and soluble IL-6Rα, which stimulate STAT3 phosphorylation through IL-6 trans-signaling in breast cancer cells. Here, STAT3 is linked to breast cancer.